Diabetes, Digestive, and Kidney Diseases Extramural Research in Connecticut
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $252 million to recipients in Connecticut in 200 grants from fiscal 2021 to 2025, 2.6% of the program's national total. Yale Univ received the most, $207 million.
- Awarded in Connecticut$252 million
- Awards200
- Share of the program2.6%
- Rank among states14th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 109 | $48.1 million |
| FY 2022 | 112 | $49.2 million |
| FY 2023 | 116 | $53.6 million |
| FY 2024 | 108 | $51.0 million |
| FY 2025 | 97 | $50.5 million |
Recipients in Connecticut
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Yale Univ | Colleges and universities | 166 | $207 million |
| University of Connecticut Health Center | Colleges and universities | 11 | $13.2 million |
| University of Connecticut Health Center | Colleges and universities | 14 | $11.0 million |
| Connecticut Children's Medical Center | Nonprofits | 2 | $8.8 million |
| Carogen Corp | Small businesses | 1 | $3.0 million |
| Thetis Pharmaceuticals LLC | Small businesses | 1 | $3.0 million |
| Hartford Hospital | Nonprofits | 2 | $2.5 million |
| Mitotherapeutix, LLC | Small businesses | 1 | $2.1 million |
| The Amino Company LLC | Small businesses | 1 | $1.7 million |
| Panluminate Inc | Small businesses | 1 | $274,391 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Connecticut?
$252 million from fiscal 2021 to 2025, across 200 awards. Connecticut ranks 14th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Connecticut?
The largest recipient is Yale Univ, with $207 million in 166 awards. Next are University of Connecticut Health Center and University of Connecticut Health Center.
Can organizations in Connecticut apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Connecticut
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Temporary Assistance for Needy Families
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- USAID Foreign Assistance for Programs Overseas
- Special Education Grants to States
- Title I Grants to Local Educational Agencies